PD-1/PD-Ls与多发性硬化的相关性研究进展

[11] Downregulation of Immunosuppressive Molecules, PD-1 and PD-L1 but not PD-L2, in the Patients with Multiple Sclerosis [J]. IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY, 2016, 15 (04) : 296 - 302

[12] Role of the innate and adaptive immune responses in the course of multiple sclerosis [J]. LANCET NEUROLOGY, 2015, 14 (04): : 406 - 419

[13] PD-1 Interaction with PD-L1 but not PD-L2 on B-cells Mediates Protective Effects of Estrogen against EAE[J] . Bodhankar Sheetal,Galipeau Danielle,Vandenbark Arthur A,Offner Halina.Journal of clinical ＆ cellular immunology . 2013 (3)

[14] Oestrogen treatment of experimental autoimmune encephalomyelitis requires 17β-oestradiol-receptor-positive B cells that up-regulate PD-1 on CD4+ Foxp3+ regulatory T cells [J]. IMMUNOLOGY, 2012, 137 (04) : 282 - 293

[15] Human brain endothelial cells endeavor to immunoregulate CD8 T cells via PD-1 ligand expression in multiple sclerosis [J]. JOURNAL OF NEUROINFLAMMATION, 2011, 8

[16] The Majority of Infiltrating CD8 T Lymphocytes in Multiple Sclerosis Lesions is Insensitive to Enhanced PD-L1 Levels on CNS Cells [J]. GLIA, 2011, 59 (05) : 841 - 856

[17] Effects of interferon-beta on co-signaling molecules: upregulation of CD40, CD86 and PD-L2 on monocytes in relation to clinical response to interferon-beta treatment in patients with multiple sclerosis[J] . Wiesemann Elke,Deb Milani,Trebst Corinna,Hemmer Bernhard,Stangel Martin,Windhagen Anja.Multiple sclerosis （Houndmills, Basingstoke, England） . 2008 (2)

[18] Innate immunity in multiple sclerosis: myeloid dendritic cells in secondary progressive multiple sclerosis are activated and drive a proinflammatory immune response[J] . Karni Arnon,Abraham Michal,Monsonego Alon,Cai Guifang,Freeman Gordon J,Hafler David,Khoury Samia J,Weiner Howard L.Journal of immunology （Baltimore, Md. : 1950） . 2006 (6)

[19] Differential Role of Programmed Death-Ligand 1 and Programmed Death-Ligand 2 in Regulating the Susceptibility and Chronic Progression of Experimental Autoimmune Encephalomyelitis[J] . Zhu Bing,Guleria Indira,Khosroshahi Arezou,Chitnis Tanuja,Imitola Jaime,Azuma Miyuki,Yagita Hideo,Sayegh Mohamed H.,Khoury Samia J..The Journal of Immunology . 2006 (6)

[20] Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 （PD-L1）, a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis[J] . Schreiner Bettina,Mitsdoerffer Meike,Kieseier Bernd C,Chen Lieping,Hartung Hans-Peter,Weller Michael,Wiendl Heinz.Journal of neuroimmunology . 2004 (1-2)

[11] Downregulation of Immunosuppressive Molecules, PD-1 and PD-L1 but not PD-L2, in the Patients with Multiple Sclerosis [J]. IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY, 2016, 15 (04) : 296 - 302

[12] Role of the innate and adaptive immune responses in the course of multiple sclerosis [J]. LANCET NEUROLOGY, 2015, 14 (04): : 406 - 419

[13] PD-1 Interaction with PD-L1 but not PD-L2 on B-cells Mediates Protective Effects of Estrogen against EAE[J] . Bodhankar Sheetal,Galipeau Danielle,Vandenbark Arthur A,Offner Halina.Journal of clinical ＆ cellular immunology . 2013 (3)

[14] Oestrogen treatment of experimental autoimmune encephalomyelitis requires 17β-oestradiol-receptor-positive B cells that up-regulate PD-1 on CD4+ Foxp3+ regulatory T cells [J]. IMMUNOLOGY, 2012, 137 (04) : 282 - 293

[15] Human brain endothelial cells endeavor to immunoregulate CD8 T cells via PD-1 ligand expression in multiple sclerosis [J]. JOURNAL OF NEUROINFLAMMATION, 2011, 8

[16] The Majority of Infiltrating CD8 T Lymphocytes in Multiple Sclerosis Lesions is Insensitive to Enhanced PD-L1 Levels on CNS Cells [J]. GLIA, 2011, 59 (05) : 841 - 856

[17] Effects of interferon-beta on co-signaling molecules: upregulation of CD40, CD86 and PD-L2 on monocytes in relation to clinical response to interferon-beta treatment in patients with multiple sclerosis[J] . Wiesemann Elke,Deb Milani,Trebst Corinna,Hemmer Bernhard,Stangel Martin,Windhagen Anja.Multiple sclerosis （Houndmills, Basingstoke, England） . 2008 (2)

[18] Innate immunity in multiple sclerosis: myeloid dendritic cells in secondary progressive multiple sclerosis are activated and drive a proinflammatory immune response[J] . Karni Arnon,Abraham Michal,Monsonego Alon,Cai Guifang,Freeman Gordon J,Hafler David,Khoury Samia J,Weiner Howard L.Journal of immunology （Baltimore, Md. : 1950） . 2006 (6)

[19] Differential Role of Programmed Death-Ligand 1 and Programmed Death-Ligand 2 in Regulating the Susceptibility and Chronic Progression of Experimental Autoimmune Encephalomyelitis[J] . Zhu Bing,Guleria Indira,Khosroshahi Arezou,Chitnis Tanuja,Imitola Jaime,Azuma Miyuki,Yagita Hideo,Sayegh Mohamed H.,Khoury Samia J..The Journal of Immunology . 2006 (6)

[20] Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 （PD-L1）, a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis[J] . Schreiner Bettina,Mitsdoerffer Meike,Kieseier Bernd C,Chen Lieping,Hartung Hans-Peter,Weller Michael,Wiendl Heinz.Journal of neuroimmunology . 2004 (1-2)